Nasdaq bid price compliance regained; equity compliance deadline extended to May 19

Tvardi Therapeutics, Inc.

Cara regained Nasdaq minimum bid price compliance after 1-for-12 reverse stock split effective Dec 30; letter received Jan 16.
Stockholders' equity of $707k at Sep 30 below $2.5M minimum; extension granted to May 19, 2025.
Extension conditional on closing proposed merger with Tvardi, which is expected to meet initial listing criteria.
Company must also satisfy all applicable Nasdaq initial listing standards at merger close.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.